Showing results (1-10 of 302) with videos related to
Sort By:
Pageof 31
Neurobiology of Disease|November 8, 2021
GluA3-containing AMPA receptors: From physiology to synaptic dysfunction in brain disordersMaria Italia, Elena Ferrari, Monica Di Luca, et al.Biomedicines|July 27, 2022
NMDA and AMPA Receptors at Synapses: Novel Targets for Tau and α-Synuclein ProteinopathiesMaria Italia, Elena Ferrari, Monica Diluca, et al.Current Opinion in Pharmacology|December 3, 2014
Targeting glutamatergic synapses in Parkinson's diseaseFabrizio Gardoni, Monica Di LucaNeuropharmacology|April 5, 2021
Protein-protein interactions at the NMDA receptor complex: From synaptic retention to synaptonuclear protein messengersFabrizio Gardoni, Monica Di LucaEuropean Journal of Pharmacology|July 13, 2006
New targets for pharmacological intervention in the glutamatergic synapseFabrizio Gardoni, Monica Di LucaNeuro-Degenerative Diseases|August 8, 2022
Synaptic Neurofilaments and GluN1-Neurofilament Light Chain Interaction in Experimental Models of α-SynucleinopathiesAlberto Imarisio, Elena Ferrari, Andrea Pilotto, et al.Journal of Neurochemistry|July 25, 2015
Alzheimer's disease and modern lifestyle: what is the role of stress?Elena Marcello, Fabrizio Gardoni, Monica Di LucaDrugs & Aging|March 2, 2006
Molecular rationale for the pharmacological treatment of Alzheimer's diseaseMartina Zimmermann, Fabrizio Gardoni, Monica Di LucaCurrent Opinion in Neurobiology|January 10, 2018
Synapse-to-nucleus communication: from developmental disorders to Alzheimer's diseaseElena Marcello, Monica Di Luca, Fabrizio GardoniFrontiers in Bioscience (Scholar Edition)|December 29, 2011
Alpha, beta-and gamma-secretases in Alzheimer's diseaseRoberta Epis, Elena Marcello, Fabrizio Gardoni, et al.Pageof 31